A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186

David A. Macdonald, Sarit E. Assouline, Joseph Brandwein, Suzanne Kamel-Reid, Elizabeth A. Eisenhauer, Stephen Couban, Stephen Caplan, Alison Foo, Wendy Walsh, Brian Leber

科研成果: 期刊稿件 › 文章 › 同行评审

40 引用 （Scopus）

指纹

探究 'A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186' 的科研主题。它们共同构成独一无二的指纹。

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science